Dimethylformamide Market By Type (Reactant, and Feed-Stock), End-Use Industry (Chemical, Electronics, Pharmaceutical, and Agrochemical), and By Region - Trends, Analysis and Forecast till 2030

Dimethylformamide Market accounted for USD 715.59 Million in 2020 and is estimated to be USD 1090.38 Million by 2030 and is anticipated to register a CAGR of 4.3%

Dimethylformamide is a compound with the formula (CH3)2NC (O) H and commonly abbreviated as DMF. This colourless liquid is miscible with water and therefore the majority of organic liquids. DMF may be a common solvent for chemical reactions. Dimethylformamide is odorless, but technical-grade or degraded samples often have a fishy smell due to presence of impurity of dimethylamine. Dimethylamine degradation impurities are often removed by sparging degraded samples with an inert gas like argon or by sonicating the samples under reduced pressure. As the name indicates, it's a derivative of formamide, the amide of acid. DMF may be a polar (hydrophilic) aprotic solvent with a high boiling point. It facilitates reactions that follow polar mechanisms, like SN2 reactions.

Manufacturing of pharmaceutical products

DMF is additionally utilized in the manufacture of pharmaceuticals as a solvent in peptide coupling for peptide synthesis and finds application within the development and manufacture of pesticides, films, adhesives, fibers, synthetic leathers, and surface coatings which drives the market. It’s also used as a reagent within the manufacture of aldehydes, the Bouveault aldehyde synthesis process, and Vilsmeier-Haack reaction.

Concerning harmful effects of dimethylformamide

The assembly of dimethylformamide in 2017 was quite enough to satisfy global demand for subsequent 10 years. This is often expected to disrupt the demand-supply gap within the end of the day, thus resulting in a possible decline in prices and restraining the expansion of the market. However, there's also the likelihood of older and fewer efficient plants being closed, during which case producers might achieve better profit margins. Furthermore, pressure from various regulatory bodies like Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) concerning the harmful effects of dimethylformamide on human health due to prolonged exposure is additionally expected to hamper market expansion.

Dimethylformamide Market has been segmented on the basis of drug, end-user and region

• On the basis of type, the Dimethylformamide Market has been segmented in reactant and feed stocks.
• On the basis of end-user, the Dimethylformamide Market has been segmented in Chemical, Electronics, Pharmaceutical, and Agrochemical.

Regional Insights:

For detailed understanding of market dynamics, the dimethylformamide market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific dominated the worldwide dimethylformamide (DMF) market in 2017, closely followed by North America and Europe. The region is anticipated to dominate the market throughout the forecast period due to increase in demand from emerging economies, especially India and China. Four of the world’s largest manufacturers of DMF are Chinese companies, with their production facilities based only in China. These four large players contribute about 44% of the entire global production. The market in Europe and North America is mature, and therefore the market within the regions is anticipated to expand at a sluggish pace or witness a decline within the near future.

Dimethylformamide Market Report Scope:

Dimethylformamide Market, By Type:

• Reactant
• Feed-Stock

Dimethylformamide Market, By End-User:

• Chemical
• Agrochemical
• Pharmaceutical
• Electronics

Dimethylformamide Market, By Region:

• North America
  • North America Dimethylformamide Market, By Type
  • North America Dimethylformamide Market, By End-User
  • North America Dimethylformamide Market, By Country
    • • U.S.
      • Canada
    • Europe
  • Europe Dimethylformamide Market, By Type
  • Europe Dimethylformamide Market, By End-User
  • Europe Dimethylformamide Market, By Country
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Switzerland
      • Sweden
      • Rest of Europe
    • Asia-Pacific
  • Asia-Pacific Dimethylformamide Market, By Type
  • Asia Pacific Dimethylformamide Market, By End-User
  • Asia-Pacific Dimethylformamide Market, By Country
    • • China
      • India
      • Australia & New Zealand
      • Japan
      • South Korea
      • Rest of Asia Pacific
    • Latin America
  • Latin AmericaDimethylformamide Market, By Type
  • Latin America Dimethylformamide Market, By End-User
  • Latin AmericaDimethylformamide Market, By Country
    • • Brazil
      • Mexico
      • Argentina and Chile
      • Rest of Latin America
    • Middle East
  • Middle East Dimethylformamide Market, By Type
  • Middle East Dimethylformamide Market, By End-User
  • Middle East Dimethylformamide Market, By Country
    • • GCC
      • Israel
      • Saudi Arabia
      • UAE
      • Rest of Middle East
    • Africa
  • Africa Dimethylformamide Market, By Type
  • Africa Dimethylformamide Market, By End-User
  • Africa Dimethylformamide Market, By Country
    • • North Africa
      • Central Africa
      • South Africa

Key players in the dimethylformamide market includes, BASF SE, Eastman Chemical Co., Merck & Co, Inc., Luxi Chemical Group Co., Ltd., Zhejiang Jiangshan Chemical Co., Alpha Chemika, Eastman Chemical Company, Ridhi Sidhi Chemicals, Balaji Amines ltd., and OCI Corporation. Furthermore, key players in the market are focusing on gaining approval of its novel Dimethylformamide drugs in key regions such as Europe and Asia-Pacific.

• BASF SE
• Balaji Amines ltd.
• Ridhi Sidhi Chemicals
• Eastman Chemical Company
• Alpha Chemika
• Zhejiang Jiangshan Chemical Co.
• Luxi Chemical Group Co., Ltd.
• Merck & Co, Inc.
• Eastman Chemical Co.